Topics
Circumscribed astrocytic gliomas | Treatment | Pleomorphic Xanthoastrocytoma
Home > Publications > Topics > Circumscribed astrocytic gliomas > Treatment > Pleomorphic Xanthoastrocytoma
Vermeulen E, Vander Mijnsbrugge AS,
Brock S, Vaeyens F, Dirven I, Ciçek A, Marcelis W, Klein S,
Bruneau M, Neyns B, Duerinck J.
Successful
Treatment with Dabrafenib/Trametinib of a Malignantly Transformed
and Metastasized BRAF V600E Mutant Pleiomorphic Xanthoastrocytoma:
A Case Report and Review of the Literature.
Case
Rep Oncol. 2024
Jan 3;17(1):10-16. doi:
10.1159/000534731. PMID:
38179547. Case report, Review. ˍ
Düzkalir
AH, Samanci Y, Nabeel AM, Reda WA, Tawadros SR, Abdelkarim K,
El-Shehaby AMN, Emad RM, Martínez Moreno N, Martínez
Álvarez R, Mathieu D, Niranjan A, Lunsford LD, Wei Z,
Shanahan RM, Liscak R, May J, Dono A, Blanco AI, Esquenazi Y,
Dayawansa S, Sheehan J, Tripathi M, Shepard MJ, Wegner RE,
Upadhyay R, Palmer JD, Peker S.
Pleomorphic
Xanthoastrocytoma: Multi-Institutional Evaluation of Stereotactic
Radiosurgery.
Neurosurgery.
2024 Jun 28. doi:
10.1227/neu.0000000000003083. PMID:
38940575. Observational study˰ ˍ
*Inoue H, Kuroda JI, Fujioka Y, Hata N, Mizoguchi M, Yoshii D,
Sueyoshi H, Takeshima Y, Fujimoto K, Shinojima N, Sunami K, Mikami
Y, Nakamura H, Mukasa A.
Drug-resistant
BRAF V600E-mutant recurrent pleomorphic xanthoastrocytoma,
CNS WHO Grade 3 successfully resolved
with incidental discontinuation of
combined BRAF and MEK inhibitor
therapy.
Surg
Neurol Int. 2024 Nov 15;15:417. doi:
10.25259/SNI_734_2024. PMID:
39640311. Case report. ˍ